According to Astellas Pharma's latest financial reports the company's current revenue (TTM ) is โน1.360 Trillion. In 2025 the company made a revenue of โน1.236 Trillion an increase over the revenue in the year 2024 that were of โน1.045 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.